Edwards Lifesciences
Price & Volume
Stats
See more52W Range | $65.94-$87.21 |
Market Cap | $49.9B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $5.8B |
Revenue Growth (YoY) | 14.7% |
Gross Profit (12 Mos) | $4.6B |
Diluted EPS | $2.28 |
News
See moreYahoo Finance • 22 days ago
Notable healthcare headlines for the week: UNH, Eli Lilly and Merck in focus
Yahoo Finance • 24 days ago
Closing Bell Movers: Amazon soars to all-time highs on earnings
Yahoo Finance • 24 days ago
Edwards Lifesciences raises 2025 guidance to high end of 9–10% sales growth and $2.56–$2.62 EPS amid strong Q3
Yahoo Finance • 25 days ago
Edwards Lifesciences Announces CFO Transition Plan
About
CEO | Mr. Bernard J. Zovighian |
CFO | Mr. Scott B. Ullem |
Address | One Edwards Way, Irvine, CA, United States, 92614 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 15,800 |
